Amyloidosis is a complex disease and the program at Huntsman Cancer Institute (HCI) uses a collaborative approach to provide comprehensive medical care. Researchers are tirelessly trying to find new ...

AL (immunoglobulin light chain) amyloidosis is a rare disease that often results in progressive organ dysfunction, organ failure and eventual death. Clonal plasma cells in the bone marrow secrete free ...

(Boston) — AL (immunoglobulin light chain) amyloidosis is a rare disease that often results in progressive organ dysfunction, organ failure and eventual death. Clonal plasma cells in the bone marrow ...

Trials of monoclonal antibodies that target various forms of amyloid at different stages of Alzheimer’s disease have had mixed results. We tested solanezumab, which targets monomeric amyloid, in a ...

Managing Alzheimer’s disease requires an intricate understanding of available treatments. Michelle Sorweid, DO, MPH, sheds light on anti-amyloid antibody therapy, how it works, and what patients are ...

Transthyretin amyloidosis can sometimes cause heart or kidney failure. Learn when you may qualify for an organ transplant and what you can expect from the procedure. Transthyretin amyloidosis, or ATTR ...